IHS Chemical Week

EnviroTech :: Biotech

Boehringer Ingelheim Launches Venture Capital Fund

5:12 AM MDT | March 31, 2010 | Deepti Ramesh

Boehringer Ingelheim (Ingelheim, Germany) says it has launched a corporate venture capital fund, Boehringer Ingelheim Venture Fund (BIVF), which aims to invest in biotechnology and start-up companies that provide groundbreaking therapeutic approaches and technologies to help drive innovation in medical science. These will include new therapeutic concepts including stem cells and RNA silencing, as well as new-generation vaccines, new-generation protein or antibody technologies, new molecular targets, and/or first-in-class lead compounds, as well as disease-related...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa